ketanserin has been researched along with Temporomandibular Disorders in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Okamoto, K | 2 |
Imbe, H | 2 |
Tashiro, A | 1 |
Kimura, A | 2 |
Donishi, T | 2 |
Tamai, Y | 2 |
Senba, E | 2 |
Nishie, Y | 1 |
Matsushita, H | 1 |
2 other studies available for ketanserin and Temporomandibular Disorders
Article | Year |
---|---|
The role of peripheral 5HT2A and 5HT1A receptors on the orofacial formalin test in rats with persistent temporomandibular joint inflammation.
Topics: Animals; Arthralgia; Arthritis; Disease Models, Animal; Dose-Response Relationship, Drug; Facial Pai | 2005 |
Contribution of peripheral 5-HT2A or 5-HT3 receptors to Fos expression in the trigeminal spinal nucleus produced by acute injury to the masseter muscle during persistent temporomandibular joint inflammation in rats.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Formaldehyde; Freund's Adjuvant; | 2006 |